2,447.00p+2.00 (+0.08%)11 Jun 2021, 18:29
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.
Jump to:

Hikma Pharmaceuticals PLC Fundamentals

Company NameHikma Pharmaceuticals PLCLast Updated2021-06-11
IndustryDrug Manufacturers - Specialty & GenericSectorHealthcare
Shares in Issue231.453 mMarket Cap£5.66 bn
PE Ratio19.05Dividend per Share$0.46
Dividend Yield1.5Dividend Cover3.94
EPS$1.81EPS Growth (%)-0.09
PEG0DPS Growth (%)0.0658
Debt Ratio0.2254Debt Equity Ratio0.3578
Asset Equity Ratio1.9250Cash Equity Ratio0.1615
Quick Ratio0.9815Current Ratio1.87
Price To Book Value3.7580ROCE0

Hikma Pharmaceuticals PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total
Prelim2021-03-182021-04-26GBP0.2470
Interim2020-08-202020-09-21GBP0.1200
Prelim2020-03-192020-05-07GBP0.2422
Interim2019-08-222019-09-23GBP0.1400
Prelim2019-04-042019-05-22GBP0.2000
Interim2018-08-232018-09-21GBP0.0940

Hikma Pharmaceuticals PLC Company Financials

Assets202020192018
Tangible Assets$1.07 bn$962.00 m$870.00 m
Intangible Assets$876.00 m$834.00 m$766.00 m
Investments$34.00 m$29.00 m$38.00 m
Total Fixed Assets$2.21 bn$2.08 bn$1.83 bn
Stocks$757.00 m$568.00 m$528.00 m
Debtors$662.00 m$637.00 m$674.00 m
Cash & Equivalents$347.00 m$465.00 m$297.00 m
Other Assets000
Total Assets$4.13 bn$3.93 bn$3.50 bn
Liabilities202020192018
Creditors within 1 year$1.03 bn$1.47 bn$893.00 m
Creditors after 1 year$959.00 m$330.00 m$907.00 m
Other Liabilities000
Total Liabilities$1.99 bn$1.80 bn$1.80 bn
Net assets$2.15 bn$2.13 bn$1.70 bn
Equity202020192018
Called up share capital$41.00 m$41.00 m$40.00 m
Share Premium$282.00 m$282.00 m$282.00 m
Profit / Loss$558.00 m$491.00 m$293.00 m
Other Equity$2.13 bn$2.12 bn$1.69 bn
Preference & Minorities$13.00 m$12.00 m$12.00 m
Total Capital Employed$2.15 bn$2.13 bn$1.70 bn
Ratios202020192018
Debt Ratio$0.26$0.05$0.25
Debt-to-Equity$0.36$0.05$0.33
Assets / Equity1.92501.92501.9250
Cash / Equity0.16150.16150.1615
EPS$1.66$1.82$1.15
Cash Flow202020192018
Cash from operating activities$464.00 m$472.00 m$430.00 m
Cashflow before financing$166.00 m$317.00 m$152.00 m
Increase in Cash-$117.00 m$166.00 m$56.00 m
Income202020192018
Turnover$2.34 bn$2.21 bn$2.07 bn
Cost of sales$1.14 bn$1.12 bn$1.02 bn
Gross Profit$1.20 bn$1.09 bn$1.05 bn
Operating Profit$579.00 m$493.00 m$371.00 m
Pre-Tax profit$558.00 m$491.00 m$293.00 m

Hikma Pharmaceuticals PLC Company Background

SectorHealthcare
ActivitiesFounded in the Middle East with headquarters in London, Hikma manufactures generic and in-licensed pharmaceuticals. The firm operates in three segments: injectables, generics, and branded. The majority of the company's sales are based in the U.S. and to a lesser degree in the Middle East, North Africa, and Europe.
Latest Interim Date7 Aug 2020
Latest Fiscal Year End Date25 Feb 2021

Hikma Pharmaceuticals PLC Directors

AppointedNamePosition
2021-03-17Dr. Pamela Josephine Kirby Non-Executive Director
2021-05-17Mr. Mazen Samih Taleb DarwazahExecutive Director,Vice Chairman
2014-05-15Sir David Kenneth Rowe-Ham GBENon-Executive Director
2017-05-19Mr. Michael Richard Dwyer AshtonNon-Executive Director
2014-05-15Mr. Samih DarwazahNon-Executive Director,Chairman
2021-05-17Mr. Mohammed Ali Khaldoun S Al-HusryNon-Executive Director
2016-05-12Mr. Breffni ByrneNon-Executive Director
2021-03-02Mr. Douglas Michael HurtNon-Executive Director
2018-05-18Dr. Ronald L GoodeNon-Executive Director
2021-05-17Mr. Said DarwazahExecutive Director,Chairman
2021-03-15Mr. Sigurdur Olafsson Executive Director,Chief Executive Officer
2021-03-17Mr. Robert PickeringNon-Executive Director
2021-03-17Ms. Nina HendersonNon-Executive Director
2021-03-17Mr. Patrick ButlerNon-Executive Director,Senior Independent Director
2021-03-17Mr. John Julius CastellaniNon-Executive Director
2021-03-17Ms. Cynthia L. SchwalmNon-Executive Director

Hikma Pharmaceuticals PLC Contact Details

Company NameHikma Pharmaceuticals PLC
Address1 New Burlington Place, London, W1S 2HR
Telephone+44 2073992760
Websitehttps://www.hikma.com

Hikma Pharmaceuticals PLC Advisors

AuditorPricewaterhouseCoopers LLP
Phone+44 2075835000
Fax+44 2078224652
Remuneration ConsultantWillis Towers Watson
Phone+44 2071702000
Fax+44 2071702222
SolicitorSlaughter and May
Phone+44 2076001200
Fax+44 2070905000
RegistrarCapita Asset Services
Phone+44 8716640300
Fax+44 2086392342
StockbrokerBank of America Merrill Lynch
Phone+44 2076281000
Fax+44 2078672867
SolicitorAddleshaw Goddard LLP
Phone(020) 7606 8855
Fax(020) 7606 4390
Financial PR AdviserFTI Consulting Inc
Phone+44 2037271000
Fax+44 2037271007
StockbrokerCiti
Phone+44 2079864000
Fax+44 2079862266